Filing Details

Accession Number:
0000711377-15-000007
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-04-23 17:59:54
Reporting Period:
2015-04-22
Filing Date:
2015-04-23
Accepted Time:
2015-04-23 17:59:54
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-04-22 26,000 $18.68 923,782 No 4 M Direct
Common Stock Disposition 2015-04-22 26,000 $47.01 897,782 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock (Right to Buy) Disposition 2015-04-22 26,000 $0.00 26,000 $18.68
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
374,002 2015-08-24 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 358,480 Indirect See Footnote
Footnotes
  1. Mr. Herbert owns 155,000 shares in a limited partnership, with the remainder owned in a trust for benefit of his spouse
  2. Options were granted 8/24/2010, vest in equal annual installments on the anniversary date of the grant, have five year lives, and expire on 8/24/2015